| 3UI7: reference: Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia., Yang SW, Smotryski J, McElroy WT, Tan Z, Ho G, Tulshian D, Greenlee WJ, Guzzi M, Zhang X, Mullins D, Xiao L, Hruza A, Chan TM, Rindgen D, Bleickardt C, Hodgson R, Bioorg Med Chem Lett. 2011 Nov 16. PMID: 22142545 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).